Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with eculizumab: The role of hepatocanalicular transporter variants-Reference-Cited by-同舟云学术

Persisting hyperbilirubinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with eculizumab: The role of hepatocanalicular transporter variants

Published:2017-08-23 Issue:4 Volume:99 Page:350-356
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Alashkar Ferras¹^ORCID,Weber Susanne N.²,Vance Colin³,Herich-Terhürne Dörte¹,Dührsen Ulrich¹,Lammert Frank²,Röth Alexander¹

Affiliation:

1. Department of Hematology; West German Cancer Center; University Hospital Essen; University of Duisburg-Essen; Essen Germany

2. Department of Medicine II; Saarland University Medical Center; Saarland University; Homburg Germany

3. Rheinisch-Westfälisches Institut für Wirtschaftsforschung; Essen Germany

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12927/fullpdf

Reference21 articles.

1. Update on paroxysmal nocturnal haemoglobinuria: on the long way to understand the principles of the disease;Schubert;Eur J Haematol,2015

2. Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab;Röth;Eur J Haematol,2011

3. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria;Takeda;Cell,1993

4. Management issues in paroxysmal nocturnal hemoglobinuria;Meyers;Int J Hematol,2003

5. Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems;Rosse;Int J Hematol,2003

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers and laboratory assessments for monitoring the treatment of patients with paroxysmal nocturnal hemoglobinuria: Differences between terminal and proximal complement inhibition;Blood Reviews;2023-05

2. Role of Neurite Outgrowth Inhibitor B Receptor in hepatic steatosis;Acta Histochemica;2022-12

3. The Role of FXR-Signaling Variability in the Development and Course of Non-Alcoholic Fatty Liver Disease in Children;Acta Medica (Hradec Kralove, Czech Republic);2022

4. Beneficial effects of eculizumab regardless of prior transfusions or bone marrow disease: Results of the International Paroxysmal Nocturnal Hemoglobinuria Registry;European Journal of Haematology;2020-08-11